Spots Global Cancer Trial Database for A Real-World Patient-Reported Outcomes Study in Patients With Long-Term Use of Niraparib

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: A Real-World Patient-Reported Outcomes Study in Patients With Long-Term Use of Niraparib

Official Title: Non-interventional Study to Collect Real-world Patient-Reported Outcomes Data in Platinum-Sensitive Relapsed Ovarian Cancer Patients With Long-Term Use of Niraparib

Study ID: NCT06037213

Conditions

Ovarian Cancer

Interventions

Study Description

Brief Summary: This prospective, non-interventional study is designed to evaluate the quality of life of Chinese ovarian cancer patients with long-term niraparib use in a real-world setting. Participants will complete questionnaires or accept telephone follow-up to provide information about their quality of life.

Detailed Description: In this prospective, non-interventional study, patients with platinum-sensitive relapsed ovarian cancer who have received niraparib as maintenance therapy for more than two years will agree to be contacted by questionnaire or telephone three times. The interval will be 4-6 weeks. Information on quality of life will be collected and analysed.